In Silico and In Vitro Studies of the Antimetastatic and Antiangiogenic Activities of Cordyceps militaris Extracts on Breast Cancer Cells (MDA-MB-231)
DOI:
https://doi.org/10.20883/medical.e1255Keywords:
metastasis, angiogenesis, Cordyceps militaris, breast cancerAbstract
Introduction. Cordyceps militaris (CM), a traditional medicinal fungus in East Asia, has attracted increasing attention for its anticancer potential. Despite extensive use in traditional medicine, the mechanisms underlying its antimetastatic and antiangiogenic effects in breast cancer remain unclear. This study aimed to explore the bioactive components of aqueous extracts derived from CM’s mycelium (Aq-CMM) and fruiting body (Aq-CMF), focusing on their potential inhibitory activities on metastasis and angiogenesis in triple-negative breast cancer cells (MDA-MB-231).
Materials and methods. In silico molecular docking was conducted to screen for key CM bioactive compounds and evaluate their binding affinities toward metastasis- and angiogenesis-related targets, NF-κB and VEGFR. In vitro cytotoxicity was assessed using 2D monolayer and 3D spheroid MDA-MB-231 cultures treated with Aq-CMM and Aq-CMF. Cell viability (IC₅₀) was determined at 48 hours, and microscopic evaluation of treated spheroids was performed to assess morphological disruption.
Results and conclusions. Docking analyses identified ergothioneine as a major CM-derived compound with strong binding affinity to NF-κB (−7.83 kcal/mol) and VEGFR (−7.62 kcal/mol), suggesting potent inhibitory effects on metastatic and angiogenic pathways. In vitro assays showed that Aq-CMF exerted greater growth-inhibitory effects (IC₅₀ = 54 µg/mL in 2D; 46 µg/mL in 3D) than Aq-CMM at 48 hours. Microscopic observations confirmed notable disruption of spheroid architecture following treatment. These findings highlight the therapeutic potential of ergothioneine-rich CM extracts, particularly from the fruiting body, as promising anticancer agents that warrant further mechanistic and translational studies.
Downloads
References
Jin Y, Meng X, Qiu Z, Su Y, Yu P, Qu P. Anti-tumor and anti-metastatic roles of cordycepin, one bioactive compound of Cordyceps militaris. Saudi journal of biological sciences. 2018;25(5):991-5.
Tuli HS, Sandhu SS, Sharma AK. Pharmacological and therapeutic potential of Cordyceps with special reference to Cordycepin. 3 Biotech. 2014;4(1):1-12.
Ewen Se T, Yoke Yin C, Yin Quan T, Sunita C. Implementation of Omics Approaches in Unravelling the Potency of Cordyceps militaris in Drug Discovery. The Natural Products Journal. 2025;15(1):98-118.
Quan X, Kwak BS, Lee JY, Park JH, Lee A, Kim TH, et al. Cordyceps militaris Induces Immunogenic Cell Death and Enhances Antitumor Immunogenic Response in Breast Cancer. Evidence-based complementary and alternative medicine : eCAM. 2020;2020:9053274.
Lee HH, Lee S, Lee K, Shin YS, Kang H, Cho H. Anti-cancer effect of Cordyceps militaris in human colorectal carcinoma RKO cells via cell cycle arrest and mitochondrial apoptosis. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 2015;23(1):35.
Yang CH, Kao YH, Huang KS, Wang CY, Lin LW. Cordyceps militaris and mycelial fermentation induced apoptosis and autophagy of human glioblastoma cells. Cell death & disease. 2012;3(11):e431.
Park SE, Kim J, Lee YW, Yoo HS, Cho CK. Antitumor activity of water extracts from Cordyceps militaris in NCI-H460 cell xenografted nude mice. Journal of acupuncture and meridian studies. 2009;2(4):294-300.
Park SE, Yoo HS, Jin CY, Hong SH, Lee YW, Kim BW, et al. Induction of apoptosis and inhibition of telomerase activity in human lung carcinoma cells by the water extract of Cordyceps militaris. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2009;47(7):1667-75.
Chamyuang S, Owatworakit A, Honda Y. New insights into cordycepin production in Cordyceps militaris and applications. Ann Transl Med. 2019;7(Suppl 3):S78.
Kapałczyńska M, Kolenda T, Przybyła W, Zajączkowska M, Teresiak A, Filas V, et al. 2D and 3D cell cultures - a comparison of different types of cancer cell cultures. Archives of medical science : AMS. 2018;14(4):910-9.
Liu Y, Guo ZJ, Zhou XW. Chinese Cordyceps: Bioactive Components, Antitumor Effects and Underlying Mechanism-A Review. Molecules. 2022;27(19).
Tuli HS, Sharma AK, Sandhu SS, Kashyap D. Cordycepin: A bioactive metabolite with therapeutic potential. Life Sciences. 2013;93(23):863-9.
Chen L, Zhang L, Ye X, Deng Z, Zhao C. Ergothioneine and its congeners: anti-ageing mechanisms and pharmacophore biosynthesis. Protein Cell. 2024;15(3):191-206.
Shi C, Zhang N, Feng Y, Cao J, Chen X, Liu B. Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator. Cell Physiol Biochem. 2017;41(4):1313-24.
Al-Sanea MM, Chilingaryan G, Abelyan N, Sargsyan A, Hovhannisyan S, Gasparyan H, et al. Identification of Novel Potential VEGFR-2 Inhibitors Using a Combination of Computational Methods for Drug Discovery. Life (Basel). 2021;11(10).
Hu WH, Duan R, Xia YT, Xiong QP, Wang HY, Chan GK, et al. Binding of Resveratrol to Vascular Endothelial Growth Factor Suppresses Angiogenesis by Inhibiting the Receptor Signaling. J Agric Food Chem. 2019;67(4):1127-37.
Yang T, Yao H, He G, Song L, Liu N, Wang Y, et al. Effects of Lovastatin on MDA-MB-231 Breast Cancer Cells: An Antibody Microarray Analysis. J Cancer. 2016;7(2):192-9.
Yang Y, Ren L, Li W, Zhang Y, Zhang S, Ge B, et al. GABAergic signaling as a potential therapeutic target in cancers. Biomed Pharmacother. 2023;161:114410.
Lim JY, Gew LT, Tang Y-Q. Biocomputational-mediated screening and molecular docking platforms for discovery of coumarin-derived antimelanogenesis agents. Dermatologica Sinica. 2023;41(1).
Grosdidier A, Zoete V, Michielin O. SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic acids research. 2011;39(Web Server issue):W270-7.
Ghasemi M, Turnbull T, Sebastian S, Kempson I. The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis. International journal of molecular sciences. 2021;22(23).
Li L, Hu M, Wang T, Chen H, Xu L. Repositioning Aspirin to Treat Lung and Breast Cancers and Overcome Acquired Resistance to Targeted Therapy. Frontiers in oncology. 2019;9:1503.
Putra W, Salma, W. and Widiastuti, D. . The Potency of Boesenbergin A and Boesenbergin B Compounds from Kaempferia pandurata as Anti-metastasis Agent: in silico study. Malaysian Journal of Biochemistry & Molecular Biology (MJBMB). 2020;23(3):128 - 32.
Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD. Molecular Docking and Structure-Based Drug Design Strategies. Molecules. 2015;20(7):13384-421.
Chen S-Y, Ho K-J, Hsieh Y-J, Wang L-T, Mau J-L. Contents of lovastatin, γ-aminobutyric acid and ergothioneine in mushroom fruiting bodies and mycelia. LWT. 2012;47(2):274-8.
Lin SY, Chen YK, Yu HT, Barseghyan GS, Asatiani MD, Wasser SP, et al. Comparative study of contents of several bioactive components in fruiting bodies and mycelia of culinary-medicinal mushrooms. International journal of medicinal mushrooms. 2013;15(3):315-23.
Kajal K, Panda AK, Bhat J, Chakraborty D, Bose S, Bhattacharjee P, et al. Andrographolide binds to ATP-binding pocket of VEGFR2 to impede VEGFA-mediated tumor-angiogenesis. Scientific Reports. 2019;9(1):4073.
Bhuiyan MR, Ahmed KS, Reza MS, Hossain H, Siam SMM, Nayan S, et al. Prediction of angiogenesis suppression by myricetin from Aeginetia indica via inhibiting VEGFR2 signaling pathway using computer-aided analysis. Heliyon. 2025;11(2):e41749.
Ghith A, Youssef KM, Ismail NSM, Abouzid KAM. Design, synthesis and molecular modeling study of certain VEGFR-2 inhibitors based on thienopyrimidne scaffold as cancer targeting agents. Bioorganic Chemistry. 2019;83:111-28.
Jenkham P, Wibunkul, K. , Jantakee, K., Katasai, A., Thephinlap, C. , Khoothiam, K. , Suwannasom, N. , Panya, A. and Thepmalee, C. Effect of aqueous extract from cordyceps militaris on the immune cell activation to kill breast cancer and hepatocellular carcinoma cell lines. Health Science, Science and Technology Reviews. 2023;16(1):30-45.
Berrouet C, Dorilas N, Rejniak KA, Tuncer N. Comparison of Drug Inhibitory Effects ([Formula: see text]) in Monolayer and Spheroid Cultures. Bulletin of mathematical biology. 2020;82(6):68.
Jędrejko KJ, Lazur J, Muszyńska B. Cordyceps militaris: An Overview of Its Chemical Constituents in Relation to Biological Activity. Foods (Basel, Switzerland). 2021;10(11).
Yow H-Y, Tang Y-Q, Lee J-S. Antiproliferation effect of aspirin and diclofenac on MDA-MD-231 triple-negative breast cancer cells. Malaysian Journal of Biochemistry & Molecular Biology (MJBMB). 2022;25: 88-92.
Chen BX, Xue LN, Wei T, Ye ZW, Li XH, Guo LQ, et al. Enhancement of ergothioneine production by discovering and regulating its metabolic pathway in Cordyceps militaris. Microbial cell factories. 2022;21(1):169.
Lan YH, Lu YS, Wu JY, Lee HT, Srinophakun P, Canko GN, et al. Cordyceps militaris Reduces Oxidative Stress and Regulates Immune T Cells to Inhibit Metastatic Melanoma Invasion. Antioxidants (Basel, Switzerland). 2022;11(8).
Leong HJY, Tan HD, Yap WH, Chia AYY, Zacchigna S, Tang Y-Q. Identification of Potentially Therapeutic Target Genes in Metastatic Breast Cancer via Integrative Network Analysis. EJMO. 2023;7(4).
Chan JS, Barseghyan GS, Asatiani MD, Wasser SP. Chemical Composition and Medicinal Value of Fruiting Bodies and Submerged Cultured Mycelia of Caterpillar Medicinal Fungus Cordyceps militaris CBS-132098 (Ascomycetes). International journal of medicinal mushrooms. 2015;17(7):649-59.
Wiley JL, Razdan RK, Martin BR. Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice. Life Sciences. 2006;80(1):24-35.
Saydé T, El Hamoui O, Alies B, Gaudin K, Lespes G, Battu S. Biomaterials for Three-Dimensional Cell Culture: From Applications in Oncology to Nanotechnology. Nanomaterials (Basel, Switzerland). 2021;11(2).
Rolver MG, Elingaard-Larsen LO, Pedersen SF. Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells. Journal of visualized experiments : JoVE. 2019(148).
Aggarwal V, Tuli HS, Varol A, Thakral F, Yerer MB, Sak K, et al. Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements. Biomolecules. 2019;9(11).
Virtanen SS, Kukkonen-Macchi A, Vainio M, Elima K, Härkönen PL, Jalkanen S, et al. Adenosine inhibits tumor cell invasion via receptor-independent mechanisms. Molecular cancer research : MCR. 2014;12(12):1863-74.
Kanbara K, Otsuki Y, Watanabe M, Yokoe S, Mori Y, Asahi M, et al. GABA(B) receptor regulates proliferation in the high-grade chondrosarcoma cell line OUMS-27 via apoptotic pathways. BMC cancer. 2018;18(1):263.
Zhang D, Li X, Yao Z, Wei C, Ning N, Li J. GABAergic signaling facilitates breast cancer metastasis by promoting ERK1/2-dependent phosphorylation. Cancer letters. 2014;348(1-2):100-8.
Wang W, Nag SA, Zhang R. Targeting the NFκB signaling pathways for breast cancer prevention and therapy. Current medicinal chemistry. 2015;22(2):264-89.
Choi HW, Shin PG, Lee JH, Choi WS, Kang MJ, Kong WS, et al. Anti-inflammatory effect of lovastatin is mediated via the modulation of NF-κB and inhibition of HDAC1 and the PI3K/Akt/mTOR pathway in RAW264.7 macrophages. International journal of molecular medicine. 2018;41(2):1103-9.
Xie L, Zhu G, Shang J, Chen X, Zhang C, Ji X, et al. An overview on the biological activity and anti-cancer mechanism of lovastatin. Cellular signalling. 2021;87:110122.
Khandelwal Gilman KA, Han S, Won YW, Putnam CW. Complex interactions of lovastatin with 10 chemotherapeutic drugs: a rigorous evaluation of synergism and antagonism. BMC cancer. 2021;21(1):356.
Wong YY, Moon A, Duffin R, Barthet-Barateig A, Meijer HA, Clemens MJ, et al. Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction. The Journal of biological chemistry. 2010;285(4):2610-21.
Li J, Cai H, Sun H, Qu J, Zhao B, Hu X, et al. Extracts of Cordyceps sinensis inhibit breast cancer growth through promoting M1 macrophage polarization via NF-κB pathway activation. Journal of ethnopharmacology. 2020;260:112969.
Bjornsti MA, Houghton PJ. The TOR pathway: a target for cancer therapy. Nature reviews Cancer. 2004;4(5):335-48.
Feng C, Chen R, Fang W, Gao X, Ying H, Zheng X, et al. Synergistic effect of CD47 blockade in combination with cordycepin treatment against cancer. Frontiers in pharmacology. 2023;14:1144330.
Wang D, Zhang Y, Lu J, Wang Y, Wang J, Meng Q, et al. Cordycepin, a Natural Antineoplastic Agent, Induces Apoptosis of Breast Cancer Cells via Caspase-dependent Pathways. Natural product communications. 2016;11(1):63-8.
Edmondson R, Broglie JJ, Adcock AF, Yang L. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol. 2014;12(4):207-18.
Ravi M, Paramesh V, Kaviya SR, Anuradha E, Solomon FD. 3D cell culture systems: advantages and applications. J Cell Physiol. 2015;230(1):16-26.
Lv D, Hu Z, Lu L, Lu H, Xu X. Three-dimensional cell culture: A powerful tool in tumor research and drug discovery. Oncol Lett. 2017;14(6):6999-7010.
Published
Issue
Section
License
Copyright (c) 2025 The copyright to the submitted manuscript is held by the Author, who grants the Journal of Medical Science (JMS) a nonexclusive licence to use, reproduce, and distribute the work, including for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
